Frazier Life Sciences Management, L.P. Diversified Active

Location: Palo Alto, CA

CIK: 0001892134 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 10, 2022

Total Value: $1.06B (100.0% shares, 0.0% debt)

Holdings (41)

ARQT ARCUTIS BIOTHERAPEUTICS INC 17.0%
Value $180M Shares 8,434,232 Est. Cost $16.92 Unrealized +21.3%
HILLEVAX INC 9.6%
Value $101M Shares 9,285,682 Est. Cost $10.93 Unrealized
KRYS KRYSTAL BIOTECH INC 6.8%
Value $71.92M Shares 1,095,407 Est. Cost $62.37 Unrealized -0.3%
MIRM MIRUM PHARMACEUTICALS INC 6.6%
Value $69.41M Shares 3,566,912 Est. Cost $20.40 Unrealized +15.6%
CHINOOK THERAPEUTICS INC 5.9%
Value $62.88M Shares 3,595,026 Est. Cost $16.64 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 5.8%
Value $61.48M Shares 3,195,403 Est. Cost $16.84 Unrealized -1.1%
PHAT PHATHOM PHARMACEUTICALS INC 4.6%
Value $49.18M Shares 5,827,415 Est. Cost $16.15 Unrealized -36.4%
SIERRA ONCOLOGY INC 4.5%
Value $47.88M Shares 870,636 Est. Cost $32.05 Unrealized
IMAGO BIOSCIENCES INC 3.8%
Value $39.78M Shares 2,971,274 Est. Cost $19.27 Unrealized
PCVX VAXCYTE INC 3.7%
Value $38.89M Shares 1,787,405 Est. Cost $21.85 Unrealized +5.9%
CRNX CRINETICS PHARMACEUTICALS IN 2.5%
Value $26.39M Shares 1,414,823 Est. Cost $20.24 Unrealized -1.4%
TARS TARSUS PHARMACEUTICALS INC 2.5%
Value $26.1M Shares 1,787,527 Est. Cost $17.82 Unrealized -15.8%
ALPINE IMMUNE SCIENCES INC 2.4%
Value $25.41M Shares 2,985,757 Est. Cost $8.97 Unrealized
TRICIDA INC 1.9%
Value $20.16M Shares 2,082,093 Est. Cost $8.22 Unrealized
COGT COGENT BIOSCIENCES INC 1.8%
Value $18.89M Shares 2,094,154 Est. Cost $6.96 Unrealized -2.0%
ANAB ANAPTYSBIO INC 1.7%
Value $18.26M Shares 899,700 Est. Cost $30.26 Unrealized -26.8%
GRACELL BIOTECHNOLOGIES INC 1.6%
Value $17.11M Shares 3,111,551 Est. Cost $2.33 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.5%
Value $15.47M Shares 1,572,192 Est. Cost $14.37 Unrealized -23.2%
MERUS N V 1.4%
Value $15.26M Shares 673,979 Est. Cost $26.19 Unrealized
FRAZIER LIFESCIENCES ACQU CO 1.4%
Value $14.81M Shares 1,501,000 Est. Cost $9.99 Unrealized
REPL REPLIMUNE GROUP INC 1.3%
Value $14.09M Shares 806,267 Est. Cost $18.60 Unrealized -11.7%
GRITSTONE BIO INC 1.2%
Value $12.67M Shares 5,237,348 Est. Cost $4.12 Unrealized
ARVN ARVINAS INC 1.1%
Value $12.01M Shares 285,331 Est. Cost $67.21 Unrealized -25.3%
PASSAGE BIO INC 1.1%
Value $11.82M Shares 5,009,219 Est. Cost $3.10 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 1.1%
Value $11.34M Shares 980,302 Est. Cost $19.21 Unrealized -30.1%
AUTL AUTOLUS THERAPEUTICS PLC 1.0%
Value $10.6M Shares 3,746,857 Est. Cost $4.17 Unrealized
NTLA INTELLIA THERAPEUTICS INC 1.0%
Value $10.54M Shares 203,684 Est. Cost $84.72 Unrealized -40.1%
SLN SILENCE THERAPEUTICS PLC 1.0%
Value $10.44M Shares 881,173 Est. Cost $19.00 Unrealized
TYRA TYRA BIOSCIENCES INC 0.9%
Value $9.832M Shares 1,375,065 Est. Cost $11.74 Unrealized -32.1%
SUTRO BIOPHARMA INC 0.9%
Value $9.255M Shares 1,776,479 Est. Cost $8.22 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value $5.7M Shares 408,329 Est. Cost $13.64 Unrealized +2.7%
CEREVEL THERAPEUTICS HLDNG I 0.5%
Value $5.348M Shares 202,260 Est. Cost $28.81 Unrealized
TRVI TREVI THERAPEUTICS INC 0.3%
Value $3.292M Shares 1,171,627 Est. Cost $2.46 Unrealized 0.0%
PARDES BIOSCIENCES INC 0.2%
Value $2.596M Shares 845,636 Est. Cost $7.22 Unrealized
IMVT IMMUNOVANT INC 0.2%
Value $2.284M Shares 585,759 Est. Cost $6.23 Unrealized -30.6%
ESSA PHARMA INC 0.2%
Value $2.183M Shares 692,910 Est. Cost $6.18 Unrealized
IVERIC BIO INC 0.2%
Value $1.635M Shares 170,000 Est. Cost $16.83 Unrealized
MOLECULAR TEMPLATES INC 0.1%
Value $1.253M Shares 1,374,047 Est. Cost $3.45 Unrealized
EPIZYME INC 0.1%
Value $1.087M Shares 739,369 Est. Cost $1.15 Unrealized
APTINYX INC 0.1%
Value $1.051M Shares 1,883,244 Est. Cost $2.27 Unrealized
NABRIVA THERAPEUTICS PLC 0.0%
Value $77,000 Shares 425,650 Est. Cost $0.42 Unrealized